Studies on the effectiveness of CBD

CBD bought from a CBD Flower distributor is a non-psychoactive cannabinoid, and this means it does not produce the euphoric effects associated with THC. CBD is believed to be very useful and has also proven beneficial in treating these diseases:

Multiple Sclerosis (MS)

A study conducted by researchers at the University of California found that cannabinoids bought from CBD Flower Supplier could limit neurological damage by blocking inflammatory responses in the brain. These researchers reported that patients receiving chemotherapy showed reduced pain after ingesting marijuana extracts containing large amounts of CBD.

Cancer

The Journal of Neuroscience reported that CBD significantly inhibited human breast cancer cell proliferation and metastasis in numerous laboratory animal models. Researchers concluded that CBD "may represent a novel strategy to modulate breast cancer growth and invasion." A study published in 2014 in The Journal of Molecular Cancer demonstrated that CBD inhibits the spread of pancreatic adenocarcinoma cells by targeting gene expression involved in cell migration etc. They are even used to inhibit tumour growth through direct antiproliferative, antiproliferative and induction of ceramide-dependent apoptosis.  

Crohn's Disease

Researchers at the University of Nottingham conducted a study to determine if cannabis derivatives can produce similar effects to endocannabinoids, triggering cannabinoid receptors within cells. These scientists concluded that cannabinoids could be an effective treatment for inflammatory bowel diseases like Crohn's disease, and CBD has also been shown to inhibit the growth of colon cancer cells.

Conclusion

The US Food and Drug Administration (FDA) has approved two epilepsy medications containing CBD extracts: Epidiolex (approved in June 2018), which includes 98% CBD extract, and Epidiolex (approved in September 2018), which includes 99% CBD extract.